<DOC>
	<DOC>NCT02373371</DOC>
	<brief_summary>The main objective of this study is to compare efficacy and safety of Metvix® natural daylight photodynamic therapy with those of Metvix® conventional photodynamic therapy in subjects with mild actinic keratoses (intra-individual comparison)</brief_summary>
	<brief_title>Actinic Keratoses Treatment With Metvix® in Combination With Light</brief_title>
	<detailed_description />
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis, Actinic</mesh_term>
	<mesh_term>Methyl 5-aminolevulinate</mesh_term>
	<criteria>Male or female above 18 years; Subject with clinical diagnosis of mild Actinic Keratosis (AK) on the face or the scalp with or without clinical diagnosis of moderate AK on the target areas (TAs); Subject with clinical diagnosis of at least one severe AK on TAs Subject with clinical diagnosis of other skin disease (including nonmelanoma skin cancer) on the TAs; Subject with pigmented AK on the TAs</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>